V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161618 | 20062529 | 1.84 | 62 | Neo-adjuvant (N) | 2020-01-24 | 2020-02-08 | ECX | N | N | ECX | 101841856 |
| 20161619 | 20062530 | 1.69 | 85 | null | 2019-07-18 | 2019-08-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100975023 |
| 20161620 | 20062531 | 1.71 | 61.9 | null | 2018-09-14 | 2018-09-14 | ECX | N | N | ECX | 100434046 |
| 20161621 | 20062532 | 1.76 | 73.4 | null | 2019-09-22 | 2019-09-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101357107 |
| 20161622 | 20062533 | 1.77 | 85 | Palliative (P) | 2016-04-17 | 2016-04-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100588011 |
| 20161624 | 20062534 | 1.52 | 60.3 | Neo-adjuvant (N) | 2017-08-22 | 2017-09-03 | ECX | N | N | ECX | 100413239 |
| 20161625 | 20062535 | 1.68 | 71.95 | Palliative (P) | 2016-08-01 | 2016-08-13 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100826815 |
| 20161627 | 20062536 | 1.63 | 81.7 | Palliative (P) | 2017-03-28 | 2017-03-31 | ECX | 2 | N | ECX | 100605500 |
| 20161628 | 20062537 | 1.66 | 56.2 | Palliative (P) | 2017-08-13 | 2017-08-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100990856 |
| 20161631 | 20062538 | 1.77 | 78 | Adjuvant (A) | 2019-02-07 | 2019-02-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100729192 |
| 20161632 | 20062539 | 1.8 | 111 | Palliative (P) | 2017-07-14 | 2017-07-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100569789 |
| 20161633 | 20062540 | 1.78 | 64.9 | Adjuvant (A) | 2017-05-27 | 2017-06-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101624960 |
| 20161634 | 20062541 | 1.69 | 83 | Palliative (P) | 2018-05-30 | 2018-05-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100457472 |
| 20161635 | 20062542 | 1.7 | 113.2 | null | 2019-04-26 | 2019-04-26 | CAPECITABINE + GEMCITABINE | 01 | N | CAPECITABINE + GEMCITABINE | 101399143 |
| 20161636 | 20062543 | 1.61 | 88.2 | Neo-adjuvant (N) | 2018-07-12 | 2018-07-16 | ECX | N | null | ECX | 101689221 |
| 20161637 | 20062544 | 1.77 | 107 | Adjuvant (A) | 2016-10-15 | 2016-10-29 | ECX | N | Y | ECX | 101079399 |
| 20161638 | 20062545 | null | 86 | Palliative (P) | 2016-04-06 | 2016-04-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101757025 |
| 20161640 | 20062546 | 1.65 | 67.4 | Neo-adjuvant (N) | 2018-06-28 | 2018-06-28 | ECX | null | N | ECX | 100182885 |
| 20161641 | 20062547 | 1.59 | 60.4 | null | null | 2019-10-21 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101403429 |
| 20161642 | 20062548 | null | null | Neo-adjuvant (N) | 2018-08-15 | 2018-08-25 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100784405 |
| 20161647 | 20062549 | 1.67 | 75.6 | Palliative (P) | 2018-05-21 | 2018-05-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101551847 |
| 20161648 | 20062550 | 1.78 | 97.5 | Curative (C) | 2019-04-22 | 2019-04-23 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101625140 |
| 20161650 | 20062551 | 1.82 | 92 | Neo-adjuvant (N) | 2018-07-28 | 2018-07-31 | ECX | N | N | ECX | 100926986 |
| 20161652 | 20062552 | 1.7 | 82.5 | Neo-adjuvant (N) | 2018-09-10 | 2018-09-24 | ECX | N | N | ECX | 101669059 |
| 20161654 | 20062553 | 1.61 | 61.5 | Curative (C) | 2018-05-26 | 2018-05-28 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100592967 |
| 20161655 | 20062554 | 1.71 | null | Palliative (P) | 2019-09-09 | 2019-09-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101310865 |
| 20161656 | 20062555 | 1.63 | 73.3 | Palliative (P) | 2018-10-08 | 2018-11-06 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100149146 |
| 20161658 | 20062556 | 1.86 | 69.7 | Palliative (P) | 2016-06-13 | 2016-06-16 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100990009 |
| 20161659 | 20062557 | 1.69 | 95.8 | Neo-adjuvant (N) | 2016-11-23 | 2016-12-22 | ECX | N | N | ECX | 101368571 |
| 20161660 | 20062558 | 1.77 | 69 | Neo-adjuvant (N) | 2018-08-19 | 2018-08-19 | ECX | N | N | ECX | 100954805 |
| 20161661 | 20062559 | 1.48 | 96.9 | Neo-adjuvant (N) | 2018-12-05 | 2018-12-05 | ECX | N | N | ECX | 100053333 |
| 20161662 | 20062560 | 1.66 | 71.7 | Palliative (P) | 2019-08-04 | 2019-08-18 | ECX | N | N | ECX | 100792741 |
| 20161666 | 20062561 | 1.78 | 53 | Neo-adjuvant (N) | 2018-03-26 | 2018-04-19 | ECX | 02 | N | ECX | 101018687 |
| 20161667 | 20062562 | 1.46 | 90.8 | Neo-adjuvant (N) | 2018-01-23 | 2018-01-23 | ECX | N | N | ECX | 100374832 |
| 20161669 | 20062563 | 1.54 | 61.6 | Neo-adjuvant (N) | 2017-05-18 | 2017-05-18 | ECX | 2 | N | ECX | 101635542 |
| 20161670 | 20062564 | 1.75 | 73.4 | Disease modification (D) | 2017-03-04 | 2017-03-26 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100436216 |
| 20161671 | 20062565 | 1.68 | 63.8 | null | 2017-05-01 | 2017-05-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100311721 |
| 20161673 | 20062566 | 1.62 | 71.4 | Adjuvant (A) | null | 2016-04-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101540086 |
| 20161676 | 20062567 | 1.6 | 45 | Neo-adjuvant (N) | 2017-02-13 | 2017-02-20 | ECX | 02 | Y | ECX | 100771909 |
| 20161677 | 20062568 | 1.72 | 68.7 | null | 2017-09-03 | 2017-09-25 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100967635 |
| 20161682 | 20062569 | 1.57 | 88.5 | Adjuvant (A) | 2017-05-02 | 2017-05-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101199873 |
| 20161683 | 20062570 | 1.65 | 61.8 | Palliative (P) | 2018-09-23 | 2018-10-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100071245 |
| 20161695 | 20062571 | 1.67 | null | Disease modification (D) | null | 2019-06-30 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100709467 |
| 20161699 | 20062572 | 1.8 | 83 | Adjuvant (A) | 2017-08-04 | 2017-08-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100413315 |
| 20161701 | 20062573 | 1.5 | null | Palliative (P) | 2016-10-30 | 2016-10-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100055954 |
| 20161703 | 20062574 | null | 50 | Palliative (P) | null | 2017-03-26 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101259968 |
| 20161716 | 20062575 | null | 59.5 | Neo-adjuvant (N) | 2016-12-17 | 2016-12-18 | ECX | 02 | null | ECX | 100998912 |
| 20161718 | 20062576 | 1.81 | 49.4 | Palliative (P) | 2017-06-13 | 2017-06-23 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101661574 |
| 20161720 | 20062577 | 1.49 | 82 | Neo-adjuvant (N) | 2019-01-30 | 2019-02-28 | ECX | N | N | ECX | 101733799 |
| 20161725 | 20062578 | 1.64 | 61 | Neo-adjuvant (N) | 2018-08-24 | 2018-09-09 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100222456 |